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Background: Recent studies suggest that excessive gestational weight gain (GWG) leads to adverse maternal and
fetal outcomes including weight retention in the mother and an increased risk of childhood obesity in the
offspring.
The aim of the GeliS study is to examine the effect of a lifestyle intervention programme during pregnancy to
avoid excessive GWG and, hence, to reduce pregnancy and obstetric complications as well as the risk of maternal
and offspring obesity.
Methods and design: The GeliS study is a multicentre cluster-randomized controlled trial. A total number of 2500
pregnant women (singleton pregnancy) with a pre-pregnancy BMI ≥ 18.5 kg/m2 and ≤ 40 kg/m2 will be recruited in
practices of gynaecologists and midwives in ten Bavarian regions. The intervention comprises three structured and
individualised counselling sessions on a healthy diet, regular physical activity as well as weight monitoring during
pregnancy and one session after delivery, respectively. The counselling sessions are attached to routine pre- and
postnatal visits using standardised materials and procedures. In the control regions, general recommendations for a
healthy lifestyle are given. An oral glucose tolerance test is offered to all participants.
The primary outcome is the proportion of participants with excessive GWG. Secondary outcomes include
pregnancy and obstetric complications such as frequency of gestational diabetes, preeclampsia and caesarean
sections as well as weight retention in the mothers and BMI and other health variables in the offspring. A 5-year
follow-up of both mothers and their infants is planned.
Discussion: The GeliS lifestyle intervention programme has been adapted to the existing routine health care
system for pregnant women. If shown to be effective, it could be immediately implemented in routine care.
Trial registration: The study protocol is registered at the ClinicalTrials.gov Protocol Registration System
(NCT01958307).
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The global prevalence of overweight and obesity has
reached an epidemic dimension. In this context, the
prevalence of overweight and obesity among women of
reproductive age increased substantially [1,2]. Maternal
overweight or obesity is associated with a variety of preg-
nancy and obstetric complications [3-7], such as gesta-
tional diabetes mellitus (GDM) [8], preeclampsia [9-11]
and an increased risk for macrosomia [12] and caesarean
delivery [13,14].
Likewise, recent data suggest that excessive GWG may
result in a similar risk profile. Excessive GWG was found
to be associated with an increased risk for many adverse
maternal and fetal outcomes [15,16] such as large for ges-
tational age (LGA) newborns [17-19] and long-term
maternal weight retention after delivery [20-23]. Further-
more, GWG has been reported to be a significant risk fac-
tor for childhood obesity [24-33].
To support an optimal pregnancy outcome, the US
Institute of Medicine (IOM) provided recommendations
for GWG stratified according to BMI of the women be-
fore pregnancy [16]. Unfortunately, in many countries
including the USA, but also in Germany, an increasing
proportion of pregnant women exceed these recom-
mended thresholds [16,25,34,35].
Growing evidence suggests that lifestyle during preg-
nancy and in the early postnatal period is considerably
influencing fetal and infant growth and development.
This is an important observation, as pregnancy and the
early postnatal period represent critical stages of devel-
opment for the offspring and may “programme” the risk
of metabolic disorders later in life [36,37]. To interfere
with this potentially vicious cycle [38,39], adequate inter-
vention strategies which can be introduced into medical
practice are urgently required. Some recent studies focus-
sing on a healthy lifestyle during pregnancy and consisting
of a balanced diet and regular physical activity showed a
reduction in the risk of excessive GWG [40-43].
We recently performed the FeLIPO study (acronym
for “Feasibility of a lifestyle intervention in pregnancy to
optimize maternal weight development”) to assess the
potential to prevent excessive GWG by a simple lifestyle
intervention [44]. The 2-session intervention programme
focussing on a healthy diet, regular physical activity, and
self-monitoring of body weight resulted in a significantly
lower proportion of women exceeding the IOM recom-
mendations among women in the intervention group
(38%) compared to the control group (60%, p < 0.05)
[44]. Similar to the results of a recent meta-analysis [45],
the FeLIPO study detected a trend for a decreased risk
of developing gestational diabetes in the intervention
group [44].
Based on the results of this pilot study we are planning
to examine the potential of a comprehensive lifestyleprogramme in pregnant women under “real life” condi-
tions. The GeliS project (acronym for “Gesund leben in
der Schwangerschaft”/healthy living in pregnancy) is a
public health approach focussing on the prevention of
excessive GWG by lifestyle counselling on diet and
physical activity during pregnancy, and by self-
monitoring GWG using weight gain charts. The lifestyle
intervention programme has been adapted to the German
health care system to allow immediate implementation if
it is shown to be effective at reducing the rate of excessive
GWG and associated risks.
Methods and design
Study design and setting
The GeliS trial is a multicentre and multidisciplinary
public health project in ten regions of Bavaria, a federal
state of Germany, targeting maternal and fetal health. It
is designed as a prospective, cluster-randomized, con-
trolled, open intervention trial. We perform a paired
cluster-randomization by matching five pairs of regions
according to birth figures, sociodemographic and geo-
graphic criteria. Randomization is performed within
these pairs and each pair is supervised by an expert
centre for nutrition run by the Bavarian State Ministry
of Food, Agriculture and Forestry.
Adherence to the study protocol is monitored by the
Münchner Studienzentrum at the Technical University of
Munich. The Münchner Studienzentrum is furthermore in
charge of comprehensive data management according to
current standards. The study will be conducted in accord-
ance with the declaration of Helsinki as well as with current
local regulatory requirements and laws. Written informed
consent will be given by all participants. The study protocol
was approved by the ethical committee of the Technical
University of Munich and registered at the ClinicalTrials.
gov Protocol Registration System (NCT01958307).
Power calculation
The sample size was calculated based on the proportion
of women exceeding weight gain recommendations ac-
cording to the Institute of Medicine (IOM) guidelines
and the results of the FeLIPO study which was con-
ducted as a pilot study [44]. In accordance with data
from the Bavarian perinatal register, it is expected that at
least 40% of the women (BMI > 18.5 kg/m2) will exceed
the threshold levels of IOM in the control group (Beyerlein
A, November 2009, personal communication on the
basis of Bavarian perinatal data from 2007). A decrease
to 30% in the intervention group by adopting the life-
style intervention programme is assumed. To detect
this difference in proportions with 90% power using a sig-
nificance level (alpha) of 0.05 and an intraclass correlation
coefficient of 0.5% [46], 1900 pregnant women are needed
[47]. To compensate for a possible imbalance in the
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up to 25% until delivery, 2500 participants are required
for the trial and it is planned to recruit these women in
both urban and rural regions reflecting the socioeconomic
conditions in the Bavarian population.
Study population
Inclusion criteria
Women aged 18 to 43 years with a singleton pregnancy, a
pre-pregnancy BMI ≥ 18.5 kg/m2 and ≤ 40 kg/m2, and suf-
ficient German language skills are eligible for the study.
These pregnant women are recruited before the 12th week
of gestation and written informed consent is mandatory.
Exclusion criteria
Exclusion criteria are multiple pregnancy, high risk preg-
nancy prohibiting study participation (contraindications
to exercise e.g. placenta praevia, persistent bleeding, cer-
vical incompetence etc.), pre-pregnancy diabetes mellitus
or early gestational diabetes, uncontrolled chronic diseases
(e.g. thyroid dysfunction), psychiatric or psychosomatic
diseases, and any other diseases which could interfere with
compliance according to the study protocol.
Drop-out criteria
Reasons for drop-out are complications during pregnancy
as assessed by the trial physician. Women who give birth
preterm (delivery before 37th week of gestation) will be ex-
cluded from the GWG analysis. These and other reasons
for drop-out are carefully documented.
Counsellor recruitment and qualification
All practice-based gynaecologists including their medical
staff as well as all midwives in the selected regions are
contacted via information leaflets and by phone. Partici-
pating gynaecologists, medical staff or midwives will act as
local health care providers and key communicators by
implementing counselling sessions for participating preg-
nant women in the “real-life” setting of routine care. They
have to attend a standardised qualifying seminar to en-
sure competency in lifestyle counselling and standard-
isation of the intervention. Seminar and information
material for the counsellors as well as for the pregnant
women were developed in cooperation with the net-
work “Healthy Start - Young Family Network”, a project
of IN FORM, which is funded by the German Federal
Ministry of Food and Agriculture [48].
Participant recruitment
Before the 12th week of gestation, all pregnant women
consecutively presenting in the participating practices
are invited by midwives or medical staff to take part in
the study. To check inclusion and exclusion criteria and
to obtain basic information, participating as well as non-participating women are requested to fill in a short
screening questionnaire which includes demographic
and anamnestic data relevant to the study. If women ful-
fill all criteria and are interested to participate, they re-
ceive detailed information about the study as well as a
form to provide their written informed consent. All
these materials were approved by the ethical committee.
The lifestyle intervention programme
The intervention programme consists of four structured
and partially individualised counselling sessions empha-
sizing diet, physical activity and weight monitoring
(12th-16th, 16th-20th, and 30th-34th week of gestation and
6th-8th week postpartum). The counselling sessions are
exclusively given by specifically trained and certified mid-
wives, gynaecologists or medical staff alongside routine
prenatal visits and follow a defined curriculum. Pregnant
women receive a pedometer and brochures including ex-
amples for adequate exercise and a list of local prenatal
physical exercise programmes as well as recommendations
for a balanced diet in pregnancy according to the above
mentioned recommendations on nutrition in pregnancy
[49]. Furthermore, they receive a weight gain chart accord-
ing to their baseline BMI category for self-monitoring of
weight development as proposed by the IOM [16]. Figure 1
shows the study scheme including all visits, examinations
and other procedures as well as the data that is taken from
the pregnant women/mothers and their newborns.
Visit 0 (≤ 12th week of gestation) represents the
screening examination. After checking inclusion and ex-
clusion criteria and obtaining written informed consent,
each participant obtains a folder containing questionnaires
(on dietary habits and supplements/physical activity/ma-
ternal mental health) as well as a pedometer (Beurer
GmbH, Ulm, Germany) with adequate instructions.
Visit 1 (12th-16th week of gestation): Detailed informa-
tion about healthy diet and physical activity in pregnancy is
given in a face-to-face session of 30 to 45 min. duration.
The importance of a healthy lifestyle during pregnancy and
its determining factors are explained. Pregnant women
learn to handle the principles of healthy eating and to
understand the risks of alcohol, smoking and foodborne in-
fections during pregnancy. Further advice relates to GWG,
weight monitoring and to critical nutrients in pregnancy
(folic acid, iodine, and iron). A list of adequate prenatal
physical exercise programmes, brochures including recom-
mendations for a balanced diet in pregnancy as well as a
chart for adequate weight gain according to baseline BMI
category to self-monitor weight development are handed
out. The questionnaires distributed in Visit 0 are collected.
Visit 2 (16th-20th week of gestation, 4 weeks distance
between the two visits): Specific and detailed individual
counselling targeting dietary habits and physical activity
also considering the information from the first set of
Figure 1 Study scheme of the GeliS study.
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to participate in a standardised two hour oral glucose
tolerance test (OGTT) between the 24th and 28th week
of gestation, and an appointment for the OGTT is fixed.
Visit 3 (30th-34th week of gestation): Repetition and con-
solidation of contents from the previous visits, with an
emphasis on weight monitoring. Counsellors provide infor-
mation on prenatal maternity courses, post natal exercise
classes and on specific problems, such as water retention
or back complaints. In addition, the importance of breast-
feeding is addressed. A venous EDTA blood sample for
measurement of glycosylated haemoglobin (HbA1c) is col-
lected. The second set of questionnaires is handed out.
Visit 4 (6th-8th week postpartum): The fourth counsel-
ling session includes dietary advice during breastfeeding
and information on infant feeding principles. Full breast-
feeding is recommended at least up to the age of 4 months.
If not returned yet, the second set of questionnaires is col-
lected and the third set of questionnaires (dietary habits
and intake of supplements/physical activity/post natal de-
pression/evaluation) is handed out together with a free en-
velope to return the questionnaires. Maternal weight is
measured and documented at each visit.
Control group
Participants in the control group receive standard pre-
natal care, including a leaflet about a healthy lifestyle inpregnancy, but no specific individual advice on diet,
physical activity or weight gain in pregnancy is given.
Data collection and distribution of questionnaires take
place within routine prenatal care visits at the same time
periods as in the intervention group.
Study outcomes
Primary outcome
The primary outcome parameter is the proportion of
participating women with excessive GWG as defined by
the Institute of Medicine (IOM) [16].
Secondary outcomes
Secondary outcome parameters include:
– incidence of gestational diabetes (24th-28th week of
gestation, via an oral glucose tolerance test),
glycosylated haemoglobin concentration (30th-34th
week of gestation),
– other pregnancy complications such as
preeclampsia,
– anthropometric measures and health status of the
newborns (birth weight, height, head
circumference, LGA, small for gestational age
(SGA), APGAR-Score, pH),
– obstetric complications (mode of delivery, induction
of labour, rate of caesarean sections etc.),
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pregnancy and after delivery,
– maternal body weight after delivery (6-8 weeks
postpartum),
– maternal mental health and post natal depression.
Follow-Up
It is planned to add a follow-up observation programme
up to the age of 5 years. Follow-up parameters include
breastfeeding and infant feeding practices, growth devel-
opment and health status of the offspring (including
weight and height measurement) as well as maternal
weight development.
Outcome measures and data collection
Weight measurements, documentation of pregnancy and
obstetric complications
GWG is calculated as the difference between maternal
weight at the last prenatal visit and weight at the first
visit. The self-reported pre-pregnancy weight is docu-
mented at the time of recruitment. At every antenatal
visit, weight, blood pressure, urine analysis data as well
as pregnancy complications are routinely documented in
the maternity card. A standard operation procedure is
provided to the participating practices detailing weight
measurement. In Germany, maternity cards are delivered
to every pregnant woman at their first gynaecological
visit as soon as pregnancy is confirmed. To retrieve data
regarding complications during pregnancy and delivery
and infant anthropometrics, practice staff will copy ma-
ternity cards and birth records at the first postnatal visit.
Questionnaires
Screening-questionnaire
All women contacted are asked to complete a short an-
onymous questionnaire containing demographic and an-
amnestic data independent of study participation.
Dietary assessment
Dietary habits are recorded twice during pregnancy and
once after delivery using a validated Food Frequency
Questionnaire (FFQ) according to the DEGS-Study
(“German Health Interview and Examination Survey for
Adults” conducted by the Robert Koch Institute) [50].
Questions on the intake of dietary supplements are
added. Women attending the intervention group receive
questionnaires at Visits 0, 3 and 4. Women in the con-
trol group receive FFQs at the same time points.
Physical activity assessment
Physical activity is assessed at three time points in both
groups (analogous to FFQs) using the validated “Pregnancy
physical activity questionnaire” (PPAQ), modestly adjustedto German habits [51]. In addition, a subgroup of women
in the intervention group (n = 250) and in the control
group (n = 250) are asked to carry a pedometer for seven
consecutive days. Daily steps are documented in a personal
diary which is handed out and completed at the same time
points as the FFQ and the PPAQ.Maternal mental health
In collaboration with the Mental Health Research Unit
of the Helmholtz Zentrum München we have defined a
questionnaire with validated elements (WHO-5; PHQ-4;
questions from the KORA study - a research platform
that is used by national and international research teams
[52]). The mental health questionnaire is handed out
and collected at the same time points as the FFQ and
the PPAQ.Post natal depression
Using the Edinburgh Postnatal Depression Scale (EPDS-
Scale) postnatal depression is recorded at 6-8 weeks after
delivery. The German version validated by Bergant et al.
[53] will be used.Evaluation
To assess the acceptance of the lifestyle programme, all
participants in the intervention group obtain an evalu-
ation form at the end of the intervention (Visit 4).OGTT and HbA1c
To test for gestational diabetes mellitus (GDM), a stan-
dardised two-hour oral glucose tolerance test (OGTT) is
offered to all participants between the 24th and 28th
week of gestation. Tests are performed by the participat-
ing gynaecological practices according to the 2011
guidelines of the German Diabetes Society (DDG) and
the German Society of Gynaecology and Obstetrics
(DGGG) [54] which is in line with the guidelines of the
International Association of the Diabetes and Pregnancy
Study Groups (IADPSG) [55]. After an overnight fast,
serum glucose level is measured before, one and two
hours after intake of 75 grams glucose (Dextro®OGT,
Roche, Mannheim). Treatment will be performed at the
discretion of the participating gynaecologist. Every partici-
pating gynaecological practice will receive information
about the DDG/DGGG guidelines for the management of
gestational diabetes [54] and is asked to consider these
principles as soon as GDM is diagnosed.
To obtain additional information on the presence and
severity of diagnosed GDM, EDTA blood is collected for
the measurement of the glycosylated haemoglobin con-
centration between the 30th and 34th week of gestation.
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Follow-up interviews (by phone call or e-mail, upon
preference) will be arranged after one, and annually up
to 5 years after delivery to record maternal body weight
as well as infant anthropometrics. The infant anthropo-
metrics are based on measured data from the well baby
check-up booklet provided to all mothers in Germany at
birth to promote regular health examinations by the
family pediatricians. This is part of the free health
check-up programme for infants in the German health
care system. The (preschool-) programme comprises
standardised health examinations at six time points dur-
ing the first year of age (immediately after delivery, 3th-
10th day of age, 4th-5th week of age, 3th-4th month of age,
6th-7th month of age, 10th-12th month of age) as well as
annually up to the age of five (21th-24th month of age,
34th-36th month of age, 46th-48th month of age, 60th-64th
month of age). In Bavaria, the programme is currently uti-
lized by approximately 84.5% of all parents [56]. All
mothers are explicitly encouraged to participate in this
programme. In addition, breastfeeding and infant feeding
practices are assessed and documented. All data are pseu-
donymised before they are transferred to data manage-
ment at the Münchner Studienzentrum for database
entry.
Discussion
Excessive GWG is well known to be associated with a
higher risk of pregnancy and birth complications
[15-19,57,58]. Moreover, excessive GWG has also been
reported to favour maternal weight retention [23] and to
promote childhood obesity [24-33]. According to recent
surveys [16,59,60], an increasing number of pregnant
women show excessive GWG as defined by the guideline
of the Institute of Medicine [16]. Therefore, there is an
urgent demand for effective strategies to stop this trend
in order to avoid its potential adverse consequences for
both mother and child.
We recently published the results of a feasibility study
performed in 8 gynaecological practices in the Munich
area using a cluster-randomized design. Two sessions of
lifestyle counselling were sufficient to achieve a signifi-
cant reduction in the percentage of women with exces-
sive GWG compared to a control group. There was also
less weight retention in the mothers at month 4 as well
as a tendency for a lower rate of gestational diabetes and
less caesarean sections [44]. These results are in line
with a number of other small intervention studies aim-
ing to limit GWG during pregnancy. Most studies
showed a moderate reduction in GWG, but were not ad-
equately powered for other outcome variables such as
GDM or obstetric complications [40-43,61-64].
The present study is based on this experience, but
aims to explore this concept of lifestyle intervention inthe routine health care system. In Germany, regular pre-
and postnatal care is well established and utilised by al-
most every pregnant woman. However, the current
health care system for pregnant women and their off-
spring is solely focussing on obstetrical aspects and, after
birth, on the functional development of the children.
Our concept is to complement this system by a lifestyle
programme combining a healthy diet, regular physical
activity, and self-monitoring of body weight to avoid ex-
cessive weight gain and its potential risks for both
mother and child.
The increased risk of long-term obesity in the offspring
of mothers with excessive GWG [24,29,30,33,57] is hy-
pothesized to result from a malprogramming process dur-
ing pregnancy and early postnatal life [3,65]. This concept
of fetal programming is attractive, but since the current
evidence is mainly based on animal data and retrospective
human association studies it has not yet been proven for
humans. Therefore, a specific feature of our trial is to look
at weight development in the children up to the age of
5 years utilising the unique health check-up system for
children in Germany. Thus, this study may also serve to
examine the hypothesis that a healthy lifestyle during
pregnancy can reduce the risk of early childhood obesity
in the offspring.
Pregnancy and lactation is not only a critical period for
long-term malprogramming, but can also be considered
as a “teachable moment” describing a life situation that is
thought to motivate women to adopt a risk-reducing
health behaviour [42]. As already seen in our feasibility
study, the compliance with a lifestyle programme may be
particularly high in this phase. In the interest of the health
of their babies, women are more responsive to lifestyle
counselling than at any other time. In addition, if the con-
cept of fetal programming turns out to be valid, a tempor-
arily limited lifestyle change may not only gain more
acceptance by women, but could have a sustained benefi-
cial effect.
In addition to the long-term follow-up of the infants,
another potential strength of the GeliS study is the “real
world” setting. The study is performed within the frame-
work of the German healthcare system and represents a
true public health approach to this upcoming health chal-
lenge. The intervention programme is paid for by the lar-
gest regional statutory health insurance and it is planned to
implement the lifestyle intervention programme into rou-
tine care if a benefit for both mother and child can be dem-
onstrated. An accompanying health economic analysis is
planned to study the cost-effectiveness of the intervention.
A weakness of the study may be that there are other po-
tentially relevant perinatal factors which may modify the
obesity risk in this early phase of life. In a recent analysis
of birth cohort data pre-pregnancy BMI was identified as
the most powerful determinant of childhood obesity [66].
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showed that only a small proportion of women followed
nutrition and lifestyle recommendations pre-pregnancy,
but this proportion increased during pregnancy [67].
Thus, prevention of excessive GWG together with the
other recommendations for a healthy lifestyle, e.g. stop-
ping smoking and alcohol consumption, may be the most
promising and practicable strategy to address the lifestyle-
associated health issues previously discussed.
In summary, the GeliS trial will examine the potential
of a strategy implemented to avoid excessive GWG and,
thus, to prevent the GWG-associated health risks for
both mother and child in the routine health care of
pregnant women. If shown to be effective, it is important
to note that the collaborating statutory health insurance
fund plans to implement the lifestyle counselling into
the routine care programme for pregnant women. Then,
promotion of a healthy lifestyle including management
of weight gain during pregnancy could become an easy
and valuable strategy for the primary prevention of ad-
verse consequences of excessive GWG in both women
and their children.
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